-
1
-
-
77957833984
-
Cancer biomarkers: Can we turn recent failures into success?
-
Diamandis EP: Cancer biomarkers: can we turn recent failures into success? J Natl Cancer Inst 2010, 102:1462-1467.
-
(2010)
J Natl Cancer Inst
, vol.102
, pp. 1462-1467
-
-
Diamandis, E.P.1
-
2
-
-
78649686020
-
Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology
-
Fredolini C, Meani F, Luchini A, Zhou W, Russo P, Ross M, Patanarut A, Tamburro D, Gambara G, Ornstein D, Odicino F, Ragnoli M, Ravaggi A, Novelli F, Collura D, D'Urso L, Muto G, Belluco C, Pecorelli S, Liotta L, Petricoin EF 3rd: Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology. AAPS J 2010, 12:504-518.
-
(2010)
AAPS J
, vol.12
, pp. 504-518
-
-
Fredolini, C.1
Meani, F.2
Luchini, A.3
Zhou, W.4
Russo, P.5
Ross, M.6
Patanarut, A.7
Tamburro, D.8
Gambara, G.9
Ornstein, D.10
Odicino, F.11
Ragnoli, M.12
Ravaggi, A.13
Novelli, F.14
Collura, D.15
D'urso, L.16
Muto, G.17
Belluco, C.18
Pecorelli, S.19
Liotta, L.20
Petricoin III, E.F.21
more..
-
3
-
-
84879050607
-
Potentials and pitfalls of clinical peptidomics and metabolomics
-
Leichtle A, Dufour JF, Fiedler GM: Potentials and pitfalls of clinical peptidomics and metabolomics. Swiss Med Wkly 2013, 143.
-
(2013)
Swiss Med Wkly
, vol.143
-
-
Leichtle, A.1
Dufour, J.F.2
Fiedler, G.M.3
-
4
-
-
53849144620
-
Strategies for discovering novel cancer biomarkers through utilization of emerging technologies
-
Kulasingam V, Diamandis EP: Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat Clin Pract Oncol 2008, 5:588-599.
-
(2008)
Nat Clin Pract Oncol
, vol.5
, pp. 588-599
-
-
Kulasingam, V.1
Diamandis, E.P.2
-
6
-
-
69549105574
-
Recent advances in mass spectrometry-based peptidome analysis
-
Hu L, Ye M, Zou H: Recent advances in mass spectrometry-based peptidome analysis. Expert Rev Proteomics 2009, 6:433-447.
-
(2009)
Expert Rev Proteomics
, vol.6
, pp. 433-447
-
-
Hu, L.1
Ye, M.2
Zou, H.3
-
7
-
-
33947272665
-
Oncopeptidomics-A commentary on opportunities and limitations
-
Tammen H, Zucht HD, Budde P: Oncopeptidomics-A commentary on opportunities and limitations. Cancer Lett 2007, 249:80-86.
-
(2007)
Cancer Lett
, vol.249
, pp. 80-86
-
-
Tammen, H.1
Zucht, H.D.2
Budde, P.3
-
8
-
-
31044436630
-
Differential exoprotease activities confer tumor-specific serum peptidome patterns
-
DOI 10.1172/JCI26022
-
Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, Olshen AB, Fleisher M, Lilja H, Brogi E, Boyd J, Sanchez-Carbayo M, Holland EC, Cordon-Cardo C, Scher HI, Tempst P: Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 2006, 116:271-284. (Pubitemid 43121812)
-
(2006)
Journal of Clinical Investigation
, vol.116
, Issue.1
, pp. 271-284
-
-
Villanueva, J.1
Shaffer, D.R.2
Philip, J.3
Chaparro, C.A.4
Erdjument-Bromage, H.5
Olshen, A.B.6
Fleisher, M.7
Lilja, H.8
Brogi, E.9
Boyd, J.10
Sanchez-Carbayo, M.11
Holland, E.C.12
Cordon-Cardo, C.13
Scher, H.I.14
Tempst, P.15
-
9
-
-
66649092902
-
Serum peptidome profiling revealed platelet factor 4 as a potential discriminating peptide associated with pancreatic cancer
-
Fiedler GM, Leichtle AB, Kase J, Baumann S, Ceglarek U, Felix K, Conrad T, Witzigmann H, Weimann A, Schutte C, Hauss J, Buchler M, Thiery J: Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer. Clin Cancer Res 2009, 15:3812-3819.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 3812-3819
-
-
Fiedler, G.M.1
Leichtle, A.B.2
Kase, J.3
Baumann, S.4
Ceglarek, U.5
Felix, K.6
Conrad, T.7
Witzigmann, H.8
Weimann, A.9
Schutte, C.10
Hauss, J.11
Buchler, M.12
Thiery, J.13
-
10
-
-
34249864811
-
A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples
-
DOI 10.1373/clinchem.2006.080721
-
Lopez MF, Mikulskis A, Kuzdzal S, Golenko E, Petricoin EF 3rd, Liotta LA, Patton WF, Whiteley GR, Rosenblatt K, Gurnani P, Nandi A, Neill S, Cullen S, O'Gorman M, Sarracino D, Lynch C, Johnson A, McKenzie W, Fishman D: A novel, high-Throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples. Clin Chem 2007, 53:1067-1074. (Pubitemid 46867523)
-
(2007)
Clinical Chemistry
, vol.53
, Issue.6
, pp. 1067-1074
-
-
Lopez, M.F.1
Mikulskis, A.2
Kuzdzal, S.3
Golenko, E.4
Petricoin III, E.F.5
Liotta, L.A.6
Patton, W.F.7
Whiteley, G.R.8
Rosenblatt, K.9
Gurnani, P.10
Nandi, A.11
Neill, S.12
Cullen, S.13
O'Gorman, M.14
Sarracino, D.15
Lynch, C.16
Johnson, A.17
Mckenzie, W.18
Fishman, D.19
-
11
-
-
33745602539
-
Diagnosis and management of epithelial ovarian cancer
-
DOI 10.1097/01.AOG.0000220516.34053.48, PII 0000625020060600000029
-
Bhoola S, Hoskins WJ: Diagnosis and management of epithelial ovarian cancer. Obstet Gynecol 2006, 107:1399-1410. (Pubitemid 44336908)
-
(2006)
Obstetrics and Gynecology
, vol.107
, Issue.6
, pp. 1399-1410
-
-
Bhoola, S.1
Hoskins, W.J.2
-
12
-
-
84867655788
-
From bench to bedside: Discovery of ovarian cancer biomarkers using high-Throughput technologies in the past decade
-
Leung F, Diamandis EP, Kulasingam V: From bench to bedside: discovery of ovarian cancer biomarkers using high-Throughput technologies in the past decade. Biomark Med 2012, 6:613-625.
-
(2012)
Biomark Med
, vol.6
, pp. 613-625
-
-
Leung, F.1
Diamandis, E.P.2
Kulasingam, V.3
-
13
-
-
0036320526
-
Human tissue kallikreins: A family of new cancer biomarkers
-
Diamandis EP, Yousef GM: Human tissue kallikreins: A family of new cancer biomarkers. Clin Chem 2002, 48:1198-1205. (Pubitemid 34809825)
-
(2002)
Clinical Chemistry
, vol.48
, Issue.8
, pp. 1198-1205
-
-
Diamandis, E.P.1
Yousef, G.M.2
-
14
-
-
84868633652
-
Assessment of matrix metalloproteinase-1 for marking liver cirrhosis in chronic hepatitis c patients
-
Attallah AM, Badr El-Din NK, Omran MM, Farid K, El-Wahab AH, El-Bendary M, El-Dosoky I: Assessment of matrix metalloproteinase-1 for marking liver cirrhosis in chronic hepatitis C patients. Egypt J Immunol 2011, 18:33-42.
-
(2011)
Egypt J Immunol
, vol.18
, pp. 33-42
-
-
Attallah, A.M.1
Badr El-Din, N.K.2
Omran, M.M.3
Farid, K.4
El-Wahab, A.H.5
El-Bendary, M.6
El-Dosoky, I.7
-
15
-
-
0023092839
-
Increased levels of platelet-activating factor in blood from patients with cirrhosis of the liver
-
Caramelo C, Fernandez-Gallardo S, Santos JC, Inarrea P, Sanchez-Crespo M, Lopez-Novoa JM, Hernando L: Increased levels of platelet-Activating factor in blood from patients with cirrhosis of the liver. Eur J Clin Invest 1987, 17:7-11. (Pubitemid 17020038)
-
(1987)
European Journal of Clinical Investigation
, vol.17
, Issue.1
, pp. 7-11
-
-
Caramelo, C.1
Fernandez-Gallardo, S.2
Santos, J.C.3
-
16
-
-
14844298757
-
Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease
-
El-Gindy I, El Rahman AT, El-Alim MA, Zaki SS: Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease. Egypt J Immunol 2003, 10:27-35.
-
(2003)
Egypt J Immunol
, vol.10
, pp. 27-35
-
-
El-Gindy, I.1
El, R.A.T.2
El-Alim, M.A.3
Zaki, S.S.4
-
17
-
-
0031942036
-
Comparison of matrix metalloproteinase expression in normal and cirrhotic human liver
-
DOI 10.1007/s004280050149
-
Lichtinghagen R, Breitenstein K, Arndt B, Kuhbacher T, Boker KH: Comparison of matrix metalloproteinase expression in normal and cirrhotic human liver. Virchows Arch 1998, 432:153-158. (Pubitemid 28072607)
-
(1998)
Virchows Archiv
, vol.432
, Issue.2
, pp. 153-158
-
-
Lichtinghagen, R.1
Breitenstein, K.2
Arndt, B.3
Kuhbacher, T.4
Boker, K.H.W.5
-
18
-
-
66149138899
-
Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers
-
Kuk C, Kulasingam V, Gunawardana CG, Smith CR, Batruch I, Diamandis EP: Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers. Mol Cell Proteomics 2009, 8:661-669.
-
(2009)
Mol Cell Proteomics
, vol.8
, pp. 661-669
-
-
Kuk, C.1
Kulasingam, V.2
Gunawardana, C.G.3
Smith, C.R.4
Batruch, I.5
Diamandis, E.P.6
-
19
-
-
79957592170
-
Human urinary peptide database for multiple disease biomarker discovery
-
Siwy J, Mullen W, Golovko I, Franke J, Zurbig P: Human urinary peptide database for multiple disease biomarker discovery. Proteomics Clin Appl 2011, 5:367-374.
-
(2011)
Proteomics Clin Appl
, vol.5
, pp. 367-374
-
-
Siwy, J.1
Mullen, W.2
Golovko, I.3
Franke, J.4
Zurbig, P.5
-
20
-
-
84855743960
-
Decreased concentrations of retinol-binding protein 4 in sera of epithelial ovarian cancer patients: A potential biomarker identified by proteomics
-
Lorkova L, Pospisilova J, Lacheta J, Leahomschi S, Zivny J, Cibula D, Zivny J, Petrak J: Decreased concentrations of retinol-binding protein 4 in sera of epithelial ovarian cancer patients: A potential biomarker identified by proteomics. Oncol Rep 2012, 27:318-324.
-
(2012)
Oncol Rep
, vol.27
, pp. 318-324
-
-
Lorkova, L.1
Pospisilova, J.2
Lacheta, J.3
Leahomschi, S.4
Zivny, J.5
Cibula, D.6
Zivny, J.7
Petrak, J.8
-
21
-
-
60449090503
-
Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer
-
Camuzcuoglu H, Arioz DT, Toy H, Kurt S, Celik H, Erel O: Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer. Gynecol Oncol 2009, 112:481-485.
-
(2009)
Gynecol Oncol
, vol.112
, pp. 481-485
-
-
Camuzcuoglu, H.1
Arioz, D.T.2
Toy, H.3
Kurt, S.4
Celik, H.5
Erel, O.6
-
22
-
-
21844472565
-
Paraoxonase (PON1) 55 and 192 polymorphism and its effects to oxidant-antioxidant system in Turkish patients with type 2 diabetes mellitus
-
Agachan B, Yilmaz H, Ergen HA, Karaali ZE, Isbir T: Paraoxonase (PON1) 55 and 192 polymorphism and its effects to oxidant-Antioxidant system in turkish patients with type 2 diabetes mellitus. Physiol Res 2005, 54:287-293. (Pubitemid 40956771)
-
(2005)
Physiological Research
, vol.54
, Issue.3
, pp. 287-293
-
-
Agachan, B.1
Yilmaz, H.2
Ergen, H.A.3
Karaali, Z.E.4
Isbir, T.5
-
23
-
-
54049101738
-
Genetic polymorphisms in the paraoxonase 1 gene and risk of ovarian epithelial carcinoma
-
Lurie G, Wilkens LR, Thompson PJ, McDuffie KE, Carney ME, Terada KY, Goodman MT: Genetic polymorphisms in the Paraoxonase 1 gene and risk of ovarian epithelial carcinoma. Cancer Epidemiol Biomarkers Prev 2008, 17:2070-2077.
-
(2008)
Cancer Epidemiol Biomarkers Prev
, vol.17
, pp. 2070-2077
-
-
Lurie, G.1
Wilkens, L.R.2
Thompson, P.J.3
McDuffie, K.E.4
Carney, M.E.5
Terada, K.Y.6
Goodman, M.T.7
-
24
-
-
84879899584
-
Altered expression of sialylated glycoproteins in ovarian cancer sera using lectin-based ELISA assay and quantitative glycoproteomics analysis
-
Wu J, Xie X, Nie S, Buckanovich RJ, Lubman DM: Altered Expression of Sialylated Glycoproteins in Ovarian Cancer Sera Using Lectin-based ELISA Assay and Quantitative Glycoproteomics Analysis. J Proteome Res 2013, 12:3342-3352.
-
(2013)
J Proteome Res
, vol.12
, pp. 3342-3352
-
-
Wu, J.1
Xie, X.2
Nie, S.3
Buckanovich, R.J.4
Lubman, D.M.5
-
25
-
-
84880879871
-
Ficolin-2 and ficolin-3 in women with malignant and benign ovarian tumours
-
Szala A, Sawicki S, Swierzko AS, Szemraj J, Sniadecki M, Michalski M, Kaluzynski A, Lukasiewicz J, Maciejewska A, Wydra D, Kilpatrick DC, Matsushita M, Cedzynski M: Ficolin-2 and ficolin-3 in women with malignant and benign ovarian tumours. Cancer Immunol Immunother 2013, 62:1411-1419.
-
(2013)
Cancer Immunol Immunother
, vol.62
, pp. 1411-1419
-
-
Szala, A.1
Sawicki, S.2
Swierzko, A.S.3
Szemraj, J.4
Sniadecki, M.5
Michalski, M.6
Kaluzynski, A.7
Lukasiewicz, J.8
Maciejewska, A.9
Wydra, D.10
Kilpatrick, D.C.11
Matsushita, M.12
Cedzynski, M.13
-
26
-
-
84866135063
-
Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS
-
Wu J, Xie X, Liu Y, He J, Benitez R, Buckanovich RJ, Lubman DM: Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS. J Proteome Res 2012, 11:4541-4552.
-
(2012)
J Proteome Res
, vol.11
, pp. 4541-4552
-
-
Wu, J.1
Xie, X.2
Liu, Y.3
He, J.4
Benitez, R.5
Buckanovich, R.J.6
Lubman, D.M.7
-
27
-
-
84884682059
-
Ovarian cancer ascites-derived vitronectin and fibronectin: Combined purification, molecular features and effects on cell response
-
Carduner L, Agniel R, Kellouche S, Picot CR, Blanc-Fournier C, Leroy-Dudal J, Carreiras F: Ovarian cancer ascites-derived vitronectin and fibronectin: Combined purification, molecular features and effects on cell response. Biochim Biophys Acta 2013, 1830:4885-4897.
-
(2013)
Biochim Biophys Acta
, vol.1830
, pp. 4885-4897
-
-
Carduner, L.1
Agniel, R.2
Kellouche, S.3
Picot, C.R.4
Blanc-Fournier, C.5
Leroy-Dudal, J.6
Carreiras, F.7
-
28
-
-
41849105806
-
The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin
-
DOI 10.1172/JCI33775
-
Kenny HA, Kaur S, Coussens LM, Lengyel E: The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J Clin Invest 2008, 118:1367-1379. (Pubitemid 351500430)
-
(2008)
Journal of Clinical Investigation
, vol.118
, Issue.4
, pp. 1367-1379
-
-
Kenny, H.A.1
Kaur, S.2
Coussens, L.M.3
Lengyel, E.4
-
29
-
-
84879352308
-
Mir-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1
-
Tang H, Yao L, Tao X, Yu Y, Chen M, Zhang R, Xu C: miR-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1. Int J Mol Med 2013, 32:381-388.
-
(2013)
Int J Mol Med
, vol.32
, pp. 381-388
-
-
Tang, H.1
Yao, L.2
Tao, X.3
Yu, Y.4
Chen, M.5
Zhang, R.6
Xu, C.7
-
30
-
-
69249100942
-
Quantitative proteomics analysis integrated with microarray data reveals that extracellular matrix proteins, catenins, and P53 binding protein 1 are important for chemotherapy response in ovarian cancers
-
Pan S, Cheng L, White JT, Lu W, Utleg AG, Yan X, Urban ND, Drescher CW, Hood L, Lin B: Quantitative proteomics analysis integrated with microarray data reveals that extracellular matrix proteins, catenins, and p53 binding protein 1 are important for chemotherapy response in ovarian cancers. OMICS 2009, 13:345-354.
-
(2009)
OMICS
, vol.13
, pp. 345-354
-
-
Pan, S.1
Cheng, L.2
White, J.T.3
Lu, W.4
Utleg, A.G.5
Yan, X.6
Urban, N.D.7
Drescher, C.W.8
Hood, L.9
Lin, B.10
-
31
-
-
33846807764
-
Transketolase-like 1 expression correlates with subtypes of ovarian cancer and the presence of distant metastases
-
DOI 10.1111/j.1525-1438.2007.00799.x
-
Krockenberger M, Honig A, Rieger L, Coy JF, Sutterlin M, Kapp M, Horn E, Dietl J, Kammerer U: Transketolase-like 1 expression correlates with subtypes of ovarian cancer and the presence of distant metastases. Int J Gynecol Cancer 2007, 17:101-106. (Pubitemid 46213977)
-
(2007)
International Journal of Gynecological Cancer
, vol.17
, Issue.1
, pp. 101-106
-
-
Krockenberger, M.1
Honig, A.2
Rieger, L.3
Coy, J.F.4
Sutterlin, M.5
Kapp, M.6
Horn, E.7
Dietl, J.8
Kammerer, U.9
-
32
-
-
18744369076
-
Increased activity of lysosomal enzymes in the peritoneal fluid of patients with gynecologic cancers and pelvic inflammatory disease
-
DOI 10.1007/s00432-004-0649-5
-
Beratis NG, Kaperonis A, Eliopoulou MI, Kourounis G, Tzingounis VA: Increased activity of lysosomal enzymes in the peritoneal fluid of patients with gynecologic cancers and pelvic inflammatory disease. J Cancer Res Clin Oncol 2005, 131:371-376. (Pubitemid 40674622)
-
(2005)
Journal of Cancer Research and Clinical Oncology
, vol.131
, Issue.6
, pp. 371-376
-
-
Beratis, N.G.1
Kaperonis, A.2
Eliopoulou, M.I.3
Kourounis, G.4
Tzingounis, V.A.5
-
33
-
-
84867835307
-
Haptoglobin phenotype and epithelial ovarian cancer
-
Mandato VD, Magnani E, Abrate M, Casali B, Nicoli D, Farnetti E, Formisano D, Pirillo D, Ciarlini G, De Iaco P, Strada I, Zamagni C, La Sala GB: Haptoglobin phenotype and epithelial ovarian cancer. Anticancer Res 2012, 32:4353-4358.
-
(2012)
Anticancer Res
, vol.32
, pp. 4353-4358
-
-
Mandato, V.D.1
Magnani, E.2
Abrate, M.3
Casali, B.4
Nicoli, D.5
Farnetti, E.6
Formisano, D.7
Pirillo, D.8
Ciarlini, G.9
De Iaco, P.10
Strada, I.11
Zamagni, C.12
La Sala, G.B.13
-
34
-
-
33846818675
-
Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer
-
DOI 10.1593/neo.06619
-
Zhao C, Annamalai L, Guo C, Kothandaraman N, Koh SC, Zhang H, Biswas A, Choolani M: Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer. Neoplasia 2007, 9:1-7. (Pubitemid 46203929)
-
(2007)
Neoplasia
, vol.9
, Issue.1
, pp. 1-7
-
-
Zhao, C.1
Annamalai, L.2
Guo, C.3
Kothandaraman, N.4
Koh, S.C.L.5
Zhang, H.6
Biswas, A.7
Choolani, M.8
|